2106. Desirability of Outcome Ranking (DOOR): Application to a Phase 3 Registrational Trial Evaluating Sulopenem for Patients with Complicated Intra-abdominal Infection (cIAI)
Aronin S, Dunne M, Gupta J, Puttagunta S. 2106. Desirability of Outcome Ranking (DOOR): Application to a Phase 3 Registrational Trial Evaluating Sulopenem for Patients with Complicated Intra-abdominal Infection (cIAI). Open Forum Infectious Diseases 2023, 10: ofad500.1730. PMCID: PMC10678622, DOI: 10.1093/ofid/ofad500.1730.Peer-Reviewed Original Research